Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2023-04-26 2023-04-25
Drug Identification Number 02248642 02248642
Brand name OCTREOTIDE ACETATE OMEGA OCTREOTIDE ACETATE OMEGA
Common or Proper name Octreotide Acetate Injection Octreotide Acetate Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients OCTREOTIDE OCTREOTIDE
Strength(s) 200MCG 200MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 1 x 5 mL vial / fiole 1 x 5 mL vial / fiole
ATC code H01CB H01CB
ATC description HYPOTHALAMIC HORMONES HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-04-21 2023-04-21
Estimated end date 2023-04-28 2023-04-28
Actual end date 2023-04-25 2023-04-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments